R. Willemze
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 39
- Hematopoietic Stem Cell Transplantation 37
- Chronic Myeloid Leukemia Treatments 23
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 27
- Immunology top 5%
- Immune Cell Function and Interaction 18
- Immunotherapy and Immune Responses 11
- Oncology top 2%
-
- Lymphoma Diagnosis and Treatment 21
-
- Acute Lymphoblastic Leukemia research 25
- Co-authors
- Willem E. FibbeSicco A. ScherjonWilly A. NoortHumphrey H.H. KanhaiFrans H.J. ClaasR. OtterJ. HermansJ.H. Frederik Falkenburg
- Cited by
- HematologyGeneticsImmunology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- NetherlandsItalyFrance
In The Last Decade
R. Willemze
126 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Hematology 1.7k
- Genetics 1.6k
- Immunology 856
- Oncology 1.0k
- Pathology and Forensic Medicine 458
Countries citing papers authored by R. Willemze
This map shows the geographic impact of R. Willemze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Willemze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Willemze more than expected).
Fields of papers citing papers by R. Willemze
This network shows the impact of papers produced by R. Willemze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Willemze. The network helps show where R. Willemze may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Willemze, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 7 | |
| 2 | 2007 | 36 | |
| 3 | 2007 | 97 | |
| 4 | 2002 | 20 | |
| 5 | 2002 | 47 | |
| 6 | 2001 | 35 | |
| 7 | 2001 | 66 | |
| 8 | Antibodies to the beta 2-integrins LFA-1 and Mac-1 synergistically enhance stem cell mobilization induced by G-CSF | 1999 | 1 |
| 9 | 1998 | 2 | |
| 10 | No expression of LFA-1 on murine hematopoietic progenitor cells with colony-forming or radioprotective capacity | 1997 | 3 |
| 11 | Mechanisms of stem cell mobilization in mice | 1997 | 1 |
| 12 | 1997 | 14 | |
| 13 | 1995 | 30 | |
| 14 | 1993 | 21 | |
| 15 | 1993 | 8 | |
| 16 | 1992 | 8 | |
| 17 | 1990 | 36 | |
| 18 | 1988 | 7 | |
| 19 | Monoclonal antibodies in the histopathological diagnosis of non-Hodgkin lymphomas. | 1985 | 1 |
| 20 | Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia | 1978 | 1 |
About R. Willemze
R. Willemze is a scholar working on Hematology, Genetics and Immunology, having authored 129 papers that have together received 4.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (39 papers), Hematopoietic Stem Cell Transplantation (37 papers), Chronic Lymphocytic Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (25 papers), Chronic Myeloid Leukemia Treatments (23 papers), Lymphoma Diagnosis and Treatment (21 papers), Immune Cell Function and Interaction (18 papers) and Immunotherapy and Immune Responses (11 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (1.6k citations) and Immunology (856 citations). R. Willemze has collaborated with scholars based in Netherlands, Italy and France. Frequent co-authors include Willem E. Fibbe, Sicco A. Scherjon, Willy A. Noort, Humphrey H.H. Kanhai, Frans H.J. Claas, R. Otter, J. Hermans, J.H. Frederik Falkenburg, JH Falkenburg and Hanneke C. Kluin‐Nelemans. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.